Market Research Blog

[294 Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Market Outlook:

Ophthalmic Lasers Market- Key Highlights

• Ophthalmic lasers market shall expand steadily at a CAGR of 5.4%from 2022-2030
• Cataract surgeries shall account for the majority share of the global ophthalmic lasers market
• Femtosecond laser surgery to hold maximum sway throughout the forecast period
• North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities
• Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1529

COVID-19 Impact Analysis

The novel coronavirus pandemic will have a significantly high impact on the ophthalmic lasers market. As lockdowns and curbs continue to remain enforced, the number of footfalls across ophthalmology clinics and hospitals have declined considerably. Patient care has diminished by nearly 60%, with only emergency surgeries being permitted.

With in-patient visits becoming next to impossible, ophthalmologists are resorting to telemedicine with regards to consultation and advice to patients. A slump is anticipated in refractive and premium lens surgeries across developing economies in the long-run, attributed to cash crunches experienced by individual households due to the prolonged lockdowns.

At the same time, several countries are enforcing strict social distancing protocols and hygiene practices, keeping demand for ophthalmic laser surgeries sustained. For instance, ophthalmologists in Germany have made it a protocol to test patients requiring intravitreal injections and other procedures for COVID-19. If positive, they are redirected to emergency departments, reducing chances of infection.

“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021 & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1529

Ophthalmic lasers market by Category

By Product :

• Excimer Lasers
• Femtosecond Laser

By Application :

• Refractive Surgery
• Cataract Surgery
• Posterior Capsulotomy
• Trabeculoplasty
• Diagnostic

By End user :

• Hospital
  • 500 Bedded+
  • 250-499 Bedded
  • Less than 250
• Ambulatory Surgical Centers
• Ophthalmology Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Sealants Market Analysis and Segment Forecasts To 2022, provides an in-depth analysis of the global dental sealants market with segmentation based on  Product, End User & Region.

As per Future Market Insights’ latest revised industry analysis, the global dental sealants market is projected to reach a valuation of US$ 680 Million in 2022, likely to surge at a vigorous 4.7% CAGR between 2022 – 2032.

Demand in the market is slated to surge on the back of rising awareness and necessity for oral hygiene and dental care. In addition to this, high prevalence of lifestyle-associated dental disorders is underpinning the need for technologically advanced dental equipment, which is expected to boost the market

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14552

Dental sealants are thin plastic coatings that are applied to the chewing (occlusal) surfaces of permanent teeth (molars and premolars) to prevent decay. Molar and premolar teeth have grooves or “fissures” on their chewing surfaces decay with time. These cracks can be deep, difficult to clean, and even smaller than a single toothbrush bristle. Dental sealants give added protection to grooved and pitted areas by covering the fissured area with a smooth surface.

Rising disposable income in developing economies is fueling the preference for aesthetical and cosmetic dentistry. With the trend of beauty and wellness building interest among the general population, advancements in dental adhesives and sealants are gaining traction to secure patient or customer satisfaction.

Moreover, high prevalence of common oral diseases such as dental caries of permanent teeth is propelling sales in the market. With unhealthy lifestyles and dietary habits, the prevalence is expected to increase in the forthcoming years. High sugar intake, caffeine and smoking are the major causes of tooth decay and caries.

Rising government initiatives and investments in providing oral healthcare and awareness are anticipated to fuel sales in the market. The presence of favorable healthcare reimbursement policies in various countries will augment the growth in the market over the forecast period.

“Increasing preference for dental cosmetic procedures, along with technological advancements in materials used in dental procedures will create opportunities for growth in the forthcoming years,” says an FMI analyst.

Feel Free to Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14552

Leading Companies Profiled in Dental Sealants Market are:

• 3M
• Dentsply Sirona
• PULPDENT Corporation
• SHOFU Dental GmbH
• Den-Mat Holdings, LLC
• Centrix, Inc
• GC America Inc.
• Henkel AG & Co. KGaA
• Dux Industries, Inc.
• Johnson Services, Inc.
• Procter & Gamble
• GlaxoSmithKline plc.

Key Takeaways:

• By product, the glass ionomer segment is forecast to account for 56.6% of the total market share by 2032, with sales growing at a 3.9% CAGR.
• In terms of end user, sales in the hospitals held 44.4% of the total market share in 2021, and the trend is expected to continue over the forecast period.
• Germany will emerge as a lucrative pocket in the Europe dental sealants market, with demand growing at a 4.5% CAGR through 2032.
• China is expected to account for a lion’s share of the East Asia dental sealants market, with sales projected to increase at a 8.7% CAGR.
• The U.S. will dominate the North America dental sealants market. Total sales in the North America market will account for 30.4% of the total market share.

Competition Landscape

Key players operating in the dental sealants market are investing in product portfolio expansion to gain a competitive edge in the market. Leading players are also investing in acquisitions and partnerships to expand their global footprint. For instance:

• In December 2021, Nobel Biocare announced the U.S. FDA clearance of the company’s N1™ implant system. This implant system signifies a noteworthy step in advancing toward patient-centric implant solutions.
• In February 2022, GSK announced its independent consumer healthcare company to be called Haleon.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/14552

Key Market Segments Covered In Dental Sealants Industry Research

By Product:

• Glass Ionomer
• Polyacid Modified Resin

By End-User:

• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Global Over-The-Counter (OTC) Veterinary Drugs market is expected to grow at a decent rate owing it to the increase in number of manufacturers for Over-The-Counter (OTC) veterinary drugs, worldwide. There are variety of drugs available in the market as Over-The-Counter (OTC) veterinary drugs for the safe use in animals. These drugs are available in various forms, topical drugs are available as gels, oils, creams, and sprays for various applications. Antibiotics and non-steroidal anti-inflammatory drugs are very common Over-The-Counter (OTC) veterinary drugs in the market. The drugs are available for various medical conditions related with the skin, eyes, and allergic reactions to the animals.

The Over-The-Counter (OTC) veterinary drugs market is well equipped with the retail pharmacies by the end user segment. Injectable drug involve vaccines, which are majorly used by the companion animals for their safety and improving their well-being. The Over-The-Counter (OTC) veterinary drugs market is expected to propel during the forecast period with the growing awareness on the safety and prevention of diseases among companion animals.

Over-The-Counter (OTC) Veterinary Drugs, also termed as non-prescription drugs are drugs that are available without any prescription. These drugs are effective and safe when all the directions on the label or directed by the healthcare professional are followed. The FDA in the U.S. considers when a specific drug is effective and safe enough to be sold over-the-counter. Over-the-counter (OTC) veterinary drugs usage is attributable to the savings on cost incurred on clinical visit and on the drug cost. There are limited veterinary drugs that are approved and available to veterinarians.

Request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9190

The veterinarians often depend on the use of different sources and types of drugs to treat their patients. Over-The-Counter (OTC) veterinary drugs are checked on the assurance of the product effectiveness, safety, and manufacturing to stringent standards for purity, quality, and potency. The FDA Centre for Veterinary Medicine (CVM) is responsible for the manufacturing and distribution of veterinary food additives and drugs. Over-The-Counter (OTC) veterinary drugs are regulated under The Federal Food, Cosmetic, and Drug ACT, which regulated statutory provisions that govern all the key regulations of Over-The-Counter (OTC) veterinary drugs. The Act formulate drugs as, “articles for use in the cure, diagnosis, treatment, mitigation, or prevention of diseases in animals or man”.

Over-The-Counter (OTC) Veterinary Drugs Market: Drivers and Restraints-

Over-The-Counter (OTC) Veterinary Drugs are poised to witness a significant growth owing it to the paradigm shift from Rx to OTC by major pharmaceutical manufacturers. Increasing tendency of people towards the health of their companion animals in developed regions, majorly, and immense cost savings with Over-The-Counter (OTC) veterinary drugs pose various advantages, further boosting demand for Over-The-Counter (OTC) veterinary drugs.

However, several serious issues with OTC drugs pertaining to inappropriate substance abuse vehemently and diagnosis of the animal might obstruct market growth for Over-The-Counter (OTC) veterinary drugs during the forecast timeframe. This has also resulted in withdrawal of various Over-The-Counter (OTC) veterinary drugs used for therapy from the market over the years. Stringent regulations regarding Over-The-Counter (OTC) veterinary drugs and substance abuse related issues might also hinder market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9190

Over-The-Counter (OTC) Veterinary Drugs Market: Region-wise Outlook

Over-The-Counter (OTC) veterinary drugs market is immensely concentrated in major developed economies like the U.S., Japan, and China. The United States is expected to witness a moderate growth due to market saturation in a few product categories. Technological advancements is however, expected to boost market growth for Over-The-Counter (OTC) veterinary drugs worldwide.

Increase in consumer appetite for Over-The-Counter (OTC) veterinary drugs for their companion animals, and growing need of curbing the veterinary-related healthcare costs is expected to fuel the market growth for Over-The-Counter (OTC) veterinary drugs in the Europe region. Increase in efforts for Over-The-Counter (OTC) veterinary drugs licensing for treatment of various diseases in animals is also expected to boost the market growth for Over-The-Counter (OTC) veterinary drugs during the forecast period. However, traditional medications for veterinary disease treatment might slow down the market growth for Over-The-Counter (OTC) veterinary drugs in the Asia-Pacific and MEA region.

Over-The-Counter (OTC) Veterinary Drugs Market: Key Market Participants

Some of the market participants in the Global Over-The-Counter (OTC) Veterinary Drugs market identified across the value chain include: Merck & Co., Inc., Zoetis, Inc., Eli Lilly and Company, Virbac, Bayer AG, Sanofi, Vetoquinol S.A., Boehringer Ingelheim International GmbH, and Dechra Pharmaceuticals PLC.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9190

Over-The-Counter (OTC) Veterinary Drugs Market: Segmentation

On the basis of Drug Class, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

• H2 Receptor Antagonists
• Non-steroidal Anti-inflammatory Drug
• Artificial Tears and Ocular Lubricants
• Antihistamine
• Antibacterial
• Glucocorticosteroid
• Antidiarrheal Agents
• Nutraceuticals
• Others

On the basis of Form, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

• Topical
• Oral
• Injectable

On the basis of Distribution Channel, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

• Retail Pharmacies
• Mail-order Pharmacies
• Hypermarkets & Supermarkets

On the basis of geography, Over-The-Counter (OTC) Veterinary Drugs Market can be segmented as:

• North- America
• Eastern Europe
• Western Europe
• Asia-Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa
• Latin America

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[228 Pages Report] According to the analyst of Future Market Insights (FMI), the leading manufacturers of connected drug delivery devices are focusing collaboration with the software companies to assess the cloud data system in their devices.

The market for connected drug delivery devices is foreseen to witness a stellar growth rate of 25.6% from 2013 to 2028 rising to a valuation of US$ 1,304.7 Mn from US$ 132.2 Mn in 2022.

Moreover, it helps the manufacturer to launch the product more conveniently and to enhance their distribution channel. Manufacturers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers properly.

The companies operating in the global connected drug delivery devices market are OPKO Health Inc., Bayer AG, 3M Company, West Pharmaceutical Services, Inc., and Teva Pharmaceutical Industries Ltd., among others.

Rapidly evolving technologies, for instance, cloud-based computing models, are enabling the healthcare industry towards a transition to a new architecture.

Cloud technology along with advances in mobility and telepresence solutions is expected to create new unwired business models capable of providing healthcare anywhere.

The use of cloud technology will increase, aided by the proliferation of mobile health applications to collect and send vital signs from wireless and wired remote patient and personal health monitoring devices. Cloud-based platforms and new IT service models will fundamentally change the healthcare business equations and create opportunities for new players to enter the industry.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2755

Growing Demand for Injectable Drug Delivery to Aid Market Growth

The rising preference for injectable drug delivery is anticipated to drive the market for sterile drugs globally. Self-administration of drugs through usage of pre-filled syringes is one of the ways that can help patients to save the fees given to a caregiver. There is an increased demand for large molecule drugs in pre-filled syringes as compared to small molecule drugs in pre-filled syringes

Following this opportunity, the manufacturers are expected to cash in on profits through introduction of smart injectable drug delivery mediums among their portfolio. The progress is expected to be more prominent in the allergic reactions (Anaphylaxis) indication segment. Further, an upsurge in the number of large molecule drugs that need to be manufactured in injectable format is expected to fuel the growth of the market. Likewise, data generated by bioavailability studies is proving to present a definitive relation between pharmacodynamics and pharmacokinetics for such sterile drugs, which is also expected to offer support to the growth of the market.

Mobile applications are also being used for the treatment of patients suffering from Alzheimer, Diabetes, COPD or Asthma. Mobile applications with the use of GPS help to track the patient location. If the patient is travelling away from the home, the caretaker can track the exact location of the patient and also track the consumption of dosage by using mobile application. Most of these applications have been developed for the cloud. Placing the wireless solution on a cloud storage system helps with connectivity issues and makes it easier to communicate across different information regimes.

Limited Knowledge and Adoption Rate among Patients to Hinder Growth Rate

The deployment of connected drug delivery devices is not yet widely promoted within the public health system. This is attributed to the high cost of the product, limited reimbursement, and dearth of awareness among the patients regarding the technology. Moreover, complexity and limited availability of the device further reduces penetration. For instance, interpretation of insulin delivery trend for analysis, is considered to be useful however, because of the complicated user interface, the patients cannot interpret them smoothly. As per the current scenario, such obstacles might directly have an adverse effect on the overall growth of the connected drug delivery devices market.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-2755

Key Segments of Connected Drug Delivery Devices Industry Survey Connected Drug Delivery Devices Market by Product Type:

• Inhalation Devices
• Injectable Devices
  • Handheld Injectable Devices
  • Wearable Injectable Devices

Connected Drug Delivery Devices Market by End User:

• Hospitals
• Clinics
• Home Care

Connected Drug Delivery Devices Market by Application:

• Anaphylaxis
• Cardiovascular
• Diabetes
• Hormone Replacement
• Others

Connected Drug Delivery Devices Market by Technology:

• Bluetooth Drug Delivery Devices
• Near Field Communication Drug Delivery Devices

Connected Drug Delivery Devices Market by Region:

• North America Connected Drug Delivery Devices Market
• Latin America Connected Drug Delivery Devices Market
• Europe Connected Drug Delivery Devices Market
• East Asia Connected Drug Delivery Devices Market
• South Asia & Pacific Connected Drug Delivery Devices Market
• Middle East & Africa (MEA) Connected Drug Delivery Devices Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs